放疗对行化疗和手术的直肠癌患者的效果分析：一项基于SEER数据库的回顾性研究
|
|
王安君, 刘宁宁
|
Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database
|
|
WANG Anjun, LIU Ningning
|
|
表3 RT+S组和S组直肠癌患者OS和CSS比较
|
Tab 3 Comparison of OS and CSS in the patients with rectal cancer between the RT+S group and the S group
|
|
| Test model | Before PSM | After PSM |
|---|
RT+S group (95%CI) | S group (95%CI) | P value | RT+S group (95%CI) | S group (95%CI) | P value |
|---|
| Log-rank | | | | | | | | Median OS/month | 149 (142‒155) | 62 (55‒72) | ‒ | 104 (93‒123) | 71 (61‒86) | ‒ | | Median CSS/month | NA | 79 (66‒107) | ‒ | NA | 107 (81‒142) | ‒ | | RMST | | | | | | | | 60 months (5 years) survival time | 52.9 (52.5‒53.3) | 44.2 (43.0‒45.3) | 0.000 | 49.8 (48.8‒50.8) | 45.4 (44.2‒46.6) | 0.000 | | 60 months (5 years) cancer specific survival time | 54.1 (53.8‒54.5) | 45.9 (44.8‒47.0) | 0.000 | 50.8 (49.8‒51.8) | 47.3 (46.1‒48.5) | 0.000 | | 120 months (10 years) survival time | 91.7 (90.6‒92.7) | 70.1 (67.3‒72.8) | 0.000 | 82.1 (79.4‒84.9) | 73.2 (70.2‒76.1) | 0.000 | | 120 months (10 years) cancer specific survival time | 97.4 (96.4‒98.4) | 75.2 (72.4‒78.1) | 0.000 | 87.1 (84.4‒89.9) | 78.7 (75.7‒81.8) | 0.000 |
|
|
|